You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade-melphalan-prednisone

Showing 26 - 50 of 1,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloma Trial in France (melphalan-prednisone-thalidomide, lenalidomide-dexamethasone)

Completed
  • Myeloma
  • Albi, France
  • +25 more
Mar 29, 2021

Multiple Myeloma, Patient Participation Trial in San Francisco, New York (Doxil, melphalan, bortezomib)

Terminated
Has Results
  • Multiple Myeloma
  • Patient Participation
  • Doxil, melphalan, bortezomib
  • San Francisco, California
  • +1 more
Jun 4, 2020

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml

Active, not recruiting
  • Multiple Myeloma
  • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
  • Placebo 1.7 ml Subcutaneous Solution
  • Graz, Austria
  • +9 more
Aug 24, 2022

Multiple Myeloma Trial in Germany (Bendamustine, Bortezomib, Prednisone)

Completed
  • Multiple Myeloma
  • Bendamustine, Bortezomib, Prednisone
  • Mannheim, Ba-Wü, Germany
  • +14 more
Oct 14, 2020

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Amyloidosis Trial in Boston (Bortezomib, Dexamethasone, Melphalan)

Completed
Has Results
  • Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
Sep 4, 2020

Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 7, 2021

Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

Completed
Has Results
  • Multiple Myeloma
  • Thalidomide+Melphalan +Bortezomib+stem cell transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Multiple Myeloma Trial in France (Carfilzomib)

Unknown status
  • Multiple Myeloma
  • Avignon, France
  • +32 more
Aug 26, 2020

Multiple Myeloma Trial in Atlanta (BeEAM)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
Oct 19, 2022

Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)

Completed
Has Results
  • Multiple Myeloma
  • Allogeneic HSCT
  • +5 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2022

Multiple Myeloma Trial in Worldwide (Bortezomib, Melphalan, Prednisone (VMP), 1 or 2 cycle(s) HDM (High Dose Melphalan), 2

Active, not recruiting
  • Multiple Myeloma
  • Bortezomib, Melphalan, Prednisone (VMP)
  • +2 more
  • Brisbane, Australia
  • +207 more
Mar 22, 2021

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Jacksonville, Rochester (lenalidomide, melphalan, prednisone)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +2 more
Sep 18, 2019

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in United States (melphalan, dexamethasone, bortezomib)

Completed
Has Results
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Scottsdale, Arizona
  • +208 more
Jan 12, 2022

Diffuse Large B Cell Lymphoma Trial in Berlin (Ibrutinib and Bortezomib + R-CHOP)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Ibrutinib and Bortezomib + R-CHOP
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
Aug 10, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib, Bortezomib, Melphalan)

Completed
Has Results
  • Multiple Myeloma
  • Fresno, California
  • +212 more
Aug 9, 2019

Multiple Myeloma Trial in United States (POM, Steroids, PLD)

Unknown status
  • Multiple Myeloma
  • Encinitas, California
  • +11 more
Aug 12, 2020

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Preterm Birth Trial (Prednisone 5Mg)

Not yet recruiting
  • Preterm Birth
  • Prednisone 5Mg
  • (no location specified)
Oct 26, 2023

Multiple Myeloma Trial in Canada (Bortezomib)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +6 more
Aug 28, 2020

Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Fludarabine and Busulfan
  • Fludarabine and Melphalan
  • Wuhan, Hubei, China
    Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023